| Predicate |
Object |
| contentType |
Journal Article |
| endingPage |
38 |
| issn |
1176-6336 |
| issueIdentifier |
1 |
| pageRange |
25-38 |
| publicationName |
Therapeutics and clinical risk management |
| startingPage |
25 |
| bibliographicCitation |
Dahl R. Ciclesonide for the treatment of asthma. Ther Clin Risk Manag. 2006 Mar;2(1):25–38. PMID: 18360579; PMCID: PMC1661651. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1e26aa3c47d424f8dc5773bdc4c199f4 |
| date |
200603 |
| identifier |
https://pubmed.ncbi.nlm.nih.gov/PMC1661651
https://pubmed.ncbi.nlm.nih.gov/18360579 |
| isPartOf |
https://portal.issn.org/resource/ISSN/1176-6336
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/33049 |
| language |
English |
| source |
https://pubmed.ncbi.nlm.nih.gov/ |
| title |
Ciclesonide for the treatment of asthma |
| discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6985
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6918155
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6918281
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5311101
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5754
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID146157455
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24848783
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5281004
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID122361612 |